
About Biohit Healthcare
Biohit Healthcare is a publicly listed company based in Helsinki (Finland) founded in 1988. Diagnostics products and servcies. Biohit Healthcare offers products and services including FAEX Sample System. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is Biohit Oyj.
Company details
Biohit Healthcare provides diagnostic products and services. Its flagship product Gastropanel is a rapid assay that detects the presence of H. pylori and atrophic gastritis from a blood sample. The company also develops and markets acetyldehyde-binding products, monoclonal antibodies and instrumentation to support automation of their ELISA tests.
- Headquarters Helsinki, Finland
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website biohithealthcare.com/fi/etusivu
- Social LinkedIn X Facebook Instagram
- Legal Name Biohit Oyj Class B
- Annual Revenue$18.48 M (USD)10.14as on Dec 31, 2025
- Net Profit$3.22 M (USD)6.62as on Dec 31, 2025
- EBITDA$4 M (USD)20.72as on Dec 31, 2025
Products & Services of Biohit Healthcare
Biohit Healthcare offers a comprehensive portfolio of products and services, including FAEX Sample System.
System for collecting and handling medical samples for diagnostics.
IPO & Listings of Biohit Healthcare
Biohit Healthcare is a publicly listed company on the OMXHEX with ticker symbol BIOBV in Finland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Oct 2007
- Listed onLSE: 0DRP
- Listed entityBiohit Oyj Class B
- Exchange sectorHealth technology
- ISINFI0009005482
- Share price2.27 EUR (-1.3% on the day) · 2026-10-14
- Market capitalisation34,972,863.00 EUR
- Price to earnings11.4
- EPS (diluted, trailing year)0.20 EUR
- Volume (last session)9,858
Financials of Biohit Healthcare
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 15.7M EUR | 2.7M EUR | 3.4M EUR |
| 2024 | 14.3M EUR | 2.6M EUR | 2.8M EUR |
| 2023 | 13.1M EUR | 1.9M EUR | 2.2M EUR |
| 2022 | 10.9M EUR | 601,000 EUR | 1.7M EUR |
| 2021 | 9.4M EUR | -1.5M EUR | 402,000 EUR |
Detailed financial statements for Biohit Healthcare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Biohit Healthcare
The website of Biohit Healthcare (biohithealthcare.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▼ 13.1% vs previous month
Websites whose visitors overlap most with Biohit Healthcare. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mylabsforlife.com | 100% | #4,982,465 | View details | ||
| walkinlab.com | 89% | 174.3K | #207,324 | View details | |
biohit.com | biohit.com | 83% | – | ||
melonbio.ru | melonbio.ru | 68% | #7,484,807 | – | |
express-test.okis.ru | express-test.okis.ru | 68% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Biohit Healthcare
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biohit Healthcare
Complete news archive for Biohit Healthcare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biohit Healthcare
Biohit Healthcare was founded in 1988.
Biohit Healthcare is headquartered in Helsinki, Finland.
Annual revenue of Biohit Healthcare is $18.48M as on Dec 31, 2025.
Biohit Healthcare provides diagnostic products and services. Its flagship product Gastropanel is a rapid assay that detects the presence of H. pylori and atrophic gastritis from a blood sample. The company also develops and markets acetyldehyde-binding products, monoclonal antibodies and instrumentation to support automation of their ELISA tests.
Biohit Healthcare offers FAEX Sample System.
Yes, Biohit Healthcare is publicly traded on OMXHEX under the ticker symbol BIOBV.
Biohit Healthcare operates through Biohit Oyj.
